Tempest Therapeutics
TPST
#10301
Rank
NZ$2.94 M
Marketcap
$0.84
Share price
-1.03%
Change (1 day)
-85.47%
Change (1 year)

EPS for Tempest Therapeutics (TPST)

EPS in 2023 (TTM): -$3.91

According to Tempest Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.00. In 2022 the company made an earnings per share (EPS) of -$5.47 an increase over its 2021 EPS that were of -$18.09.

EPS history for Tempest Therapeutics from 2021 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.91-28.58%
2022-$5.47-69.74%
2021-$18.09